Proqr Therapeutics
(PRQR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -72,974 | -51,225 | -34,184 | -15,212 | -53,247 |
| Depreciation Amortization | 2,755 | 2,095 | 1,486 | 761 | 2,690 |
| Other Working Capital | 29,572 | 6,128 | 683 | -1,625 | -5,865 |
| Other Operating Activity | 9,872 | 7,864 | 5,821 | 1,898 | 2,665 |
| Operating Cash Flow | $-30,775 | $-35,137 | $-26,195 | $-14,179 | $-53,757 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -503 | -305 | -101 | -39 | -1,056 |
| Investing Cash Flow | $-503 | $-305 | $-101 | $-39 | $-1,056 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 32,721 | 1,006 | 686 | N/A | 16,415 |
| Common Stock Issued | 130,135 | 129,278 | 103,630 | 3,883 | 840 |
| Other Financing Activity | -970 | -704 | -301 | -285 | -691 |
| Financing Cash Flow | $161,886 | $129,580 | $104,014 | $3,599 | $16,563 |
| Exchange Rate Effect | 1,527 | 555 | -1,082 | 1,022 | -3,002 |
| Beginning Cash Position | 89,724 | 89,428 | 91,377 | 91,430 | 127,881 |
| End Cash Position | 221,860 | 184,122 | 168,014 | 81,834 | 86,630 |
| Net Cash Flow | $132,136 | $94,693 | $76,637 | $-9,597 | $-41,251 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,775 | -35,137 | -26,195 | -14,179 | -53,757 |
| Capital Expenditure | -573 | -305 | -101 | -39 | -1,056 |
| Free Cash Flow | -31,347 | -35,442 | -26,296 | -14,218 | -54,812 |